Home › Essential Thrombocythemia › Illinois
Essential Thrombocythemia clinical trials in Illinois
4 studies for Essential Thrombocythemia are looking for participants at sites in Illinois.
Cities in Illinois
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
- University of Chicago Comprehensive Cancer Center, Chicago
- UC Comprehensive Cancer Center at Silver Cross, New Lenox
- University of Chicago Medicine-Orland Park, Orland Park
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT06661915A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
- University of Chicago, Chicago
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07623200A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
- University of Chicago Medical Center, Chicago
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT07008118MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
- MPN Research Foundation, Chicago
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jan 23, 2026 · NCT07362225From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.